Purchase Order 75N91019P00780
Award Date 9/16/19
Potential Completion Date 9/15/20
Potential Value $115K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
China
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This federal contract award with ID HHSN261201600713P was issued by the National Cancer Institute, a civilian agency, to Gene Square Bio-Technology LTD., a for-profit limited liability company, to provide support and scanning of DNA samples from the ASIALYMPH study. The contract has a firm fixed price of $139,808.00 and an ultimate completion date of September 15, 2017. The contract was awarded on September 16, 2016 and was not set aside for any specific business type.</p>
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Gene By Gene, LIMITED, a for-profit organization, for $16,268.00. The contract is for research SNP (single nucleotide polymorphism) arrays to support NIAID's Centralized Sequencing Initiative, which aims to understand the genetic etiology of diseases and provide genomic evaluations for NIH patients. No...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Novogene Corp Inc., a minority-owned small business, to provide laboratory services for fresh-frozen tissue samples from a study of lung cancer in Xuanwei, China. The contract, valued at $117,038.40, is a firm fixed price purchase order for the requested services. Novogene has received over 100 prime contract awards from various federal agencies since 2015...
- This is a $109,080.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Novogene Corp Inc., a minority-owned small business. The contract is for long non-coding RNA and small RNA sequencing services to identify RNA biomarkers for radiation biodosimetry. The work includes sample preparation, sequencing, and data analysis for 216 mRNA/lncRNA samples and 96 small RNA samples. This effort builds on prior successful...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $26,926 purchase order to Q Squared Solutions Expression Analysis LLC for oncogene sequencing assay services. Under this firm fixed price contract, Expression Analysis will provide sequencing of cancer-related genes to support research at the NIH Clinical Center in Bethesda, Maryland through September 30, 2023. No major subcontractors or set aside designations were identified. This purchase...
- This firm fixed price purchase order, awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute, is for $37,785.60 in mRNA and microRNA microarray profiling services to support the prediction of radiation therapy outcomes. The prime contractor is Genus Biosystems Inc., located in Northbrook, Illinois, and no set-aside designation was applied to this procurement. The contract completion date is August 19, 2024, suggesting the National Cancer...
- This firm-fixed-price purchase order for $302,039.20 was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to BostonGene Corporation. The contract is for targeted deep sequencing and bioinformatics analysis of 162 human plasma samples to support a clinical trial investigating the safety and efficacy of the Copanlisib/Rituximab combination treatment for previously untreated follicular lymphoma patients. The objective is to obtain plasma...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $21,657 purchase order to Genscript USA Inc. to produce eight BM306 protein constructs. The firm fixed price contract has a period of performance from July 17, 2023 through September 1, 2023 and will be performed in Piscataway, New Jersey. The NCI supports basic and clinical cancer research across its various centers and divisions to better understand, diagnose, and treat...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...